These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 10898446

  • 21. Comparative efficacy of a DA2/alpha2 agonist and a beta-blocker in reducing adrenergic drive and cardiac fibrosis in an experimental model of left ventricular dysfunction after coronary artery occlusion.
    Latini R, Masson S, Jeremic G, Luvarà G, Fiordaliso F, Calvillo L, Bernasconi R, Torri M, Rondelli I, Razzetti R, Bongrani S.
    J Cardiovasc Pharmacol; 1998 Apr; 31(4):601-8. PubMed ID: 9554811
    [Abstract] [Full Text] [Related]

  • 22. Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol.
    Metra M, Giubbini R, Nodari S, Boldi E, Modena MG, Dei Cas L.
    Circulation; 2000 Aug 01; 102(5):546-51. PubMed ID: 10920067
    [Abstract] [Full Text] [Related]

  • 23. Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.
    Torp-Pedersen C, Poole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A, Hanrath P, Komajda M, Lutiger B, Metra M, Remme WJ, Scherhag A, Skene A, COMET Investigators.
    Am Heart J; 2005 Feb 01; 149(2):370-6. PubMed ID: 15846279
    [Abstract] [Full Text] [Related]

  • 24. Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European Trial.
    Kveiborg B, Major-Petersen A, Christiansen B, Torp-Pedersen C.
    Vasc Health Risk Manag; 2007 Feb 01; 3(1):31-7. PubMed ID: 17583173
    [Abstract] [Full Text] [Related]

  • 25. Effect of beta-blockers on beta3-adrenoceptor expression in chronic heart failure.
    Zhao Q, Wu TG, Jiang ZF, Chen GW, Lin Y, Wang LX.
    Cardiovasc Drugs Ther; 2007 Apr 01; 21(2):85-90. PubMed ID: 17440824
    [Abstract] [Full Text] [Related]

  • 26. Carvedilol may alleviate late cardiac remodelling following surgical ventricular restoration.
    Yoshikawa E, Marui A, Tsukashita M, Nishina T, Wang J, Muranaka H, Ikeda T, Komeda M.
    Eur J Cardiothorac Surg; 2010 Feb 01; 37(2):362-7. PubMed ID: 19692266
    [Abstract] [Full Text] [Related]

  • 27. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A, Macdonald PS, Keogh AM, Kotlyar E, Mellemkjaer S, Coleman CF, Elsik M, Krum H, Hayward CS.
    J Am Coll Cardiol; 2010 Apr 27; 55(17):1780-7. PubMed ID: 20413026
    [Abstract] [Full Text] [Related]

  • 28. Ventricular remodeling in heart failure and the effect of beta-blockade.
    Udelson JE.
    Am J Cardiol; 2004 May 06; 93(9A):43B-8B. PubMed ID: 15144937
    [Abstract] [Full Text] [Related]

  • 29. Carvedilol versus metoprolol in patients undergoing direct percutaneous coronary interventions for myocardial infarction: effects on QT dynamicity.
    Bonnemeier H, Ortak J, Tölg R, Witt M, Schmidt J, Wiegand UK, Bode F, Schunkert H, Richardt G.
    Pacing Clin Electrophysiol; 2005 Jan 06; 28 Suppl 1():S217-21. PubMed ID: 15683500
    [Abstract] [Full Text] [Related]

  • 30. Beta-blocker treatment of chronic heart failure: comparison of carvedilol and metoprolol.
    Maack C, Elter T, Böhm M.
    Congest Heart Fail; 2003 Jan 06; 9(5):263-70. PubMed ID: 14564145
    [Abstract] [Full Text] [Related]

  • 31. Lowering blood pressure with beta-blockers in combination with other renin-angiotensin system blockers in patients with hypertension and type 2 diabetes: results from the GEMINI Trial.
    Wright JT, Bakris GL, Bell DS, Fonseca V, Katholi RE, McGill JB, Messerli FH, Phillips RA, Raskin P, Holdbrook FK, Lukas MA, Iyengar M.
    J Clin Hypertens (Greenwich); 2007 Nov 06; 9(11):842-9. PubMed ID: 17978591
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).
    Di Lenarda A, Remme WJ, Charlesworth A, Cleland JG, Lutiger B, Metra M, Komajda M, Torp-Pedersen C, Scherhag A, Swedberg K, Poole-Wilson PA, COMET investors.
    Eur J Heart Fail; 2005 Jun 06; 7(4):640-9. PubMed ID: 15921806
    [Abstract] [Full Text] [Related]

  • 36. Effect of carvedilol on cardiac dysfunction 4 days after myocardial infarction in rats: role of toll-like receptor 4 and β-arrestin 2.
    Liu CC, Huang Y, Zhang JH, Xu Y, Wu CH.
    Eur Rev Med Pharmacol Sci; 2013 Jun 06; 17(15):2103-10. PubMed ID: 23884833
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.